Sydney West Translational Cancer Research Centre
Forgot Password?

Prof Michael Murray: Development of novel cancer cell killing and anti-migratory agents based on omega-3-fatty acid epoxides

Jun
5
1
30
P
2
30
P

Location:

Kids Research Seminar Room

Michael Murray graduated with a Bachelor of Pharmacy with First Class Honours and a PhD in Pharmaceutical Chemistry from the University of Sydney. After undertaking postdoctoral research with CF Wilkinson in the Institute for Comparative and Environmental Toxicology at Cornell University, Ithaca, NY he returned to Westmead Hospital and was appointed as an NHMRC Research Fellow in 1987, promoted to NHMRC Senior Research Fellow in 1989 and to NHMRC Principal Research Fellow in 1994. In 1995 he received a DSc from The University of Sydney.
After 5 years at UNSW he returned in July, 2003 to the Faculty of Pharmacy at the University of Sydney before relocating to The Discipline of Pharmacology in The School of Medical Sciences in The Sydney Medical School. The Pharmacogenomics and Drug Development research laboratory is located in the Faculty's new laboratories in the Medical Foundation Building. Michael Murray is the author of 161 original papers and 37 review articles since 1982 and has presented over 70 invited seminars, workshops and symposia in Australia, North America, Singapore, Czech Republic, Germany, Thailand and the United Kingdom. He was the 2002 ASCEPT visitor to the British Toxicology Society. He has been associated with the International Society for the Study of Xenobiotics (as Councillor 1986-1989), the Australasian Society for Clinical and Experimental Pharmacologists and Toxicologists (Councillor and convenor of the Drug Metabolism, Delivery and Pharmacokinetics section 2000-2003 and Deputy Chair of the Scientific Advisory Committee 2002-present) and the Gastroenterological Society of Australia (Research Advisory Committee 1989-1995). He currently serves on the editorial boards of Toxicology and Applied Pharmacology and Xenobiotica and was a recent member of the editorial boards of Current Drug Metabolism and the Journal of Gastroenterology and Hepatology.